Search
for
Sort by
Research 571–600 of 1000+
- Drug-induced acne
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Hair loss
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Nonanal Stimulates Growth Factors via Cyclic Adenosine Monophosphate (cAMP) Signaling in Human Hair Follicle Dermal Papilla Cells
- Testosterone Treatment in Women – An Overview
- Acne
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Acne
- Diagnosis and treatment of polycystic ovarian syndrome: an update
- A review on PCOS: Its causes, symptoms, pathogenesis and management
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Cicatricial Alopecia
- Generalised Glucocorticoid Resistance
- Hormonal Therapy for Acne
- STEROID HORMONES IN GERIATRICS
- From a stem-cell–centered to a niche-centered view: the core role of collagen networks in hair loss and hair follicle miniaturization
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Polycystic ovary syndrome: An update on diagnosis and management
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- The Serum Evaluation of Sex Hormones Including DHEAs, DHT, Testosterone in Oral Lichen Planus Patients
- Enhancing hair regeneration: Recent progress in tailoring nano-structured lipid carriers through surface modification strategies
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation
- Polycystic ovarian syndrome
- Alopecia
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?